Lithium inhibits IMPase (inositol monophosphatase) activity, as well as inositol transporter function. To determine whether one or more of these mechanisms might underlie lithium's behavioural effects, we studied Impa1 (encoding IMPase) and Smit1 (sodium-myo-inositol transporter 1)-knockout mice. In brains of adult homozygous Impa1-knockout mice, IMPase activity was found to be decreased; however, inositol levels were not found to be altered. Behavioural analysis indicated decreased immobility in the forced-swim test as well as a strongly increased sensitivity to pilocarpine-induced seizures. These are behaviours robustly induced by lithium. In homozygous Smit1-knockout mice, free inositol levels were decreased in the frontal cortex and hippocampus. These animals behave like lithium-treated animals in the model of pilocarpine seizures and in the Porsolt forced-swim test model of depression. In contrast with O'Brien et al. [O'Brien, Harper, Jove, Woodgett, Maretto, Piccolo and Klein (2004) J. Neurosci. 24, 6791-6798], we could not confirm that heterozygous Gsk3b (glycogen synthase kinase 3β)-knockout mice exhibit decreased immobility in the Porsolt forced-swim test or decreased amphetamine-induced hyperactivity in a manner mimicking lithium's behavioural effects. These data support the role of inositol-related processes rather than GSK3β in the mechanism of the therapeutic action of lithium.
The phosphatidylinositol cycle and lithium
The phosphatidylinositol cycle is a key intracellular second messenger system in brain as well as in numerous other tissues [1] . The dephosphorylation of inositol 1-phosphate to inositol is accomplished by the enzyme IMPase (inositol monophosphatase). This enzyme is widely distributed throughout the body and, as such, might not be considered a likely target for therapeutic intervention. However, attention was focused early on the unique ability of lithium to inhibit this enzyme with a K i value within the therapeutic range reached during lithium treatment [2] . Lithium salts have been the standard pharmacological treatment for bipolar disorder in the last 50 years. Moreover, the mechanism of the inhibition was determined to be uncompetitive, which suggested that the inhibition could become highly rate-limiting as substrate concentrations increase during the in vivo treatment [3] .
The inositol-depletion hypothesis was proposed to explain lithium's mechanism of action [4] . This hypothesis suggests that uncompetitive inhibition of IMPase by therapeutically relevant lithium concentrations leads to an accumulation of inositol phosphates and a corresponding depletion of free myo-inositol. Attempts to prove the inositol-depletion hypothesis led to numerous studies (for a review, see [5] ). Lithium inhibition of the phosphatidylinositol cycle has been relatively easy to demonstrate in in vitro systems with low Key words: bipolar disorder, glycogen synthase kinase 3β (GSK3β), inositol monophosphatase (IMPase), knockout mouse, lithium, sodium-myo-inositol transporter (SMIT). Abbreviations used: GSK, glucogen synthase kinase; IMPase, inositol monophosophatase; SMIT1, sodium-myo-inositol transporter1. 1 To whom correspondence should be addressed (email galila@bgu.ac.il). extracellular inositol concentrations [6] . However, decrease in PtdIns turnover in vivo during chronic lithium treatment has not been demonstrated, and it has been claimed that high extracellular inositol concentrations make lithium inhibition of IMPase less relevant in in vivo situations [7] .
The inositol transporter and lithium
There are three major sources of intracellular myo-inositol: recycling in the phosphatidylinositol cycle, de novo synthesis from glucose 6-phosphate by myo-inositol-1-phosphate synthase and IMPase, and uptake from extracellular fluid [8, 9] . Dietary myo-inositol is an important source of intracellular inositol. Extracellular inositol is taken up by the cells mainly through membrane-associated transporters. The major inositol transporter is believed to be the SMIT1 (sodium-myo-inositol transporter 1), which utilizes the electrochemical gradient of Na + across the plasma membrane to import inositol [10] . The group of van Calker [10, 11] studied the effect of chronic lithium on SMIT1 in rat primary astroglia and U373 MG human astrocytoma cell line culture and found that chronic lithium decreased inositol uptake and SMIT1 mRNA markedly. This suggested that lithium might choke off inositol supplies by two mechanisms: IMPase inhibition [2] and/or inositol transporter down-regulation [10] .
Lithium-related behaviours and knockout mice
An in vivo demonstration of a lithium effect dependent on inositol is lithium-pilocarpine-induced seizures. Rodents [12] . Replenishment of inositol can reverse lithium enhancement of pilocarpine-induced seizures [13, 14] . These effects are stereospecific, since chiro-inositol, an isomer of inositol that does not enter the phosphatidylinositol cycle, had no effect [14] . Among the two genes coding for IMPase, IMPA1 is significantly more brain-abundant and its IMPase activity is lithium-inhibitable at therapeutically relevant concentrations [15, 16] . To determine the physiological functions of IMPA1 in vivo and study the potential role of IMPA1 in mediating the physiological effects of lithium, we studied a mouse model in which the IMPA1 gene was inactivated by targeted mutagenesis [17] . Homozygous Impa1 −/− mice died in utero between days 9.5 and 10.5 post-coitum, demonstrating the importance of IMPA1 in early embryonic development. Intriguingly, the embryonic lethality could be reversed by myo-inositol supplementation via the pregnant mothers. In the brains of adult Impa1 −/− mice, IMPase activity levels were found to be decreased (up to 65% in hippocampus); however, inositol levels were not found to be altered. Behavioural analysis of the Impa1 −/− mice indicated decreased immobility in the forced-swim test as well as a strongly increased sensitivity to pilocarpine-induced seizures [17] .
To determine the behavioural consequences of inositol depletion via SMIT1 inhibition, we studied the behaviour of Smit1-knockout mice created by Berry et al. [18] . The homozygotes die at birth owing to central apnoea [18] . Heterozygous Smit1-knockout mice are viable and do not show any obvious physical abnormality. Heterozygous animals were studied because the degree of lithium downregulation of SMIT1 reported previously [10, 11] appeared to be best modelled by a 50% decrease in gene dose. Indeed, decrease in brain inositol in these animals [19, 20] was comparable with that seen after chronic lithium treatment [10, 21] , but no behavioural effects were seen [19, 20] . Inositol exists in brain in multiple pools [22] , and Smit1 knockout might deplete pools in a different pattern from that by lithium treatment. We therefore decided to study homozygous Smit1-knockout mice [23] . This was made possible by the discovery that inositol supplementation of drinking water of pregnant and suckling mice rescued homozygous Smit1-knockout mice who then did not require exogenous inositol to survive as adults.
In homozygous Smit1-knockout mice, free inositol levels were decreased by 55% in the frontal cortex and by 60% in the hippocampus. There were no differences in weight or motor co-ordination by the rotarod test. They behaved similarly to lithium-treated animals in the model of pilocarpine seizures and in the Porsolt forced-swim test model of depression [23] (Table 1) .
GSK (glycogen synthase kinase) 3 and lithium
GSK3 is a multi-substrate serine/threonine kinase, acting on diverse substrates, including transcription factors, regulatory enzymes and structural proteins. The protein is encoded by two genes generating two isoforms, GSK3α and GSK3β, that are 95% identical within their catalytic domains, but have distinct flanking regions. GSK3 is highly abundant in brain, both in neurons and in glia [24] . Klein and Melton [25] reported that GSK3 is inhibited in vitro by lithium at therapeutically relevant concentrations, with a K i of approx. 2 mM [25] . Lithium was shown to inhibit GSK3β both directly and by inhibiting the dephosphorylation of the inactive form of GSK3β [26] .
Two models often used for studying the mood-stabilizing effects of lithium are the Porsolt forced-swim test model of depression and the amphetamine-induced hyperactivity model of mania [27] . O'Brien et al. [28] used a very specific regimen of lithium administration to mice and reported robust antidepressant effects in the Porsolt forced-swim test [28] , which we have replicated [29] . O'Brien et al. [28] reported that heterozygous Gsk3b-knockout mice showed an antidepressant-like decrease in immobility in the Porsolt forced-swim test, as does lithium. Beaulieu et al. [30] reported that heterozygous Gsk3b-knockout mice had a decreased locomotor response to amphetamine. Antimanic effects of lithium in the amphetamine-induced hyperactivity model were also reported by Einat et al. [27] . O'Brien et al. [28] suggested that these data provided behavioural evidence for the theory that lithium acts in both phases of bipolar disorder via inhibition of GSK3β. In order to compare the mechanism of Gsk3b knockout on behaviour with the effect of Impa1 and Smit1 knockout, we attempted to replicate in our laboratory [31] the studies of O'Brien et al. [28] and Beaulieu et al. [30] . We could not confirm the report that heterozygous Gsk3b-knockout mice exhibit decreased immobility in the Porsolt forced-swim test or decreased amphetamine-induced hyperactivity in a manner mimicking lithium's behavioural effects [31] .
Implication of the effects of gene knockouts
Homozygous Impa1-knockout mice Multiple rodent studies have shown that lithium treatment causes a sensitization to pilocarpine-induced seizures [12, 13] . Impa1 −/− mice exhibited an increased sensitivity to pilocarpine-induced seizures [17] . This finding constituted evidence that this model depends on inositol depletion. The fact that the adult Impa1 −/− mice did not show decreased inositol levels in various brain regions does not rule out inositol depletion as a mechanism of the observed seizures [13] . As mentioned above, several pools of inositol are suggested to exist in the brain [22, 32, 33] and the IMPA1-dependent inositol pool probably makes up only a small, possibly spatially delineated, but clearly significant, part. Inositol depletion as a result of dietary inositol restriction [34] or hyponatraemia [22] has been shown not to sensitize pilocarpine-induced seizures.
We reported that Smit1 −/+ mice showed a decrease in brain inositol levels by approx. 15-20%, but did not show increased pilocarpine sensitivity [19, 20] . SMIT1 in brain seems to be limited to glia cells [35] , and it may well be that most of the inositol measured in whole brain is glial inositol. The decrease in brain inositol in Impa1 −/− mice would be more likely to occur in those cells with a highly active phosphatidylinositol cycle, so that inositol is being depleted because of it being continuously used and the inability of cells to recycle it. Although acute high-dose lithium does classically decrease brain inositol in vivo, chronic lithium at therapeutically relevant concentrations has only a small (10-15%) and inconsistent effect [21] . Thus lack of marked inositol lowering in the Impa1-knockout mice might also, surprisingly, make these mice a more, rather than less, realistic model of chronic lithium treatment.
In the Impa1 −/− mice, brain IMPase activity was found to be significantly decreased (up to 65% in hippocampus); however, considerable residual IMPase activity remained [17] . The Impa1 −/− mice displayed decreased immobility in the forced-swim test, which is suggestive of an antidepressantlike phenotype. The Impa1 −/− mice were hyperactive in the open-field test and showed increased rearing as well [17] . Therefore the observed decrease in immobility might reflect increased locomotor behaviour rather than an antidepressantlike phenotype. On the other hand, the hyperactivity in the open-field test appears to be a consequence of a lack of habituation to the novel environment seen after 25 min, rather than an overall increased locomotor activity. A prominent feature in adulthood of animals receiving lithium treatment during development is hyperactivity, similar to our finding in these IMPA1-deleted mice. Furthermore, supplementing adult Impa1 −/− mice with inositol did not reverse the observed hyperactivity [17] , suggesting that the hyperactivity is not a consequence of depleted inositol in adulthood. Further testing of these animals in models of depression that are sensitive to lithium, but not dependent on activity, is required. Separation of the developmental and probably irreversible effects of early IMPA1 deletion from pharmacological effects of IMPase inhibition in adult animals could require creation of a conditional or inducible knockout of Impa1.
Smit1-knockout mice
The SMIT1 results comparing heterozygous [19, 20] and homozygous [23] knockout support the concept that inositol depletion can cause behavioural effects similar to those of lithium, including both pilocarpine-sensitivity and decreased immobility in the Porsolt forced-swim test. However, achievement of the behavioural effects required inositol depletion far greater than that achieved by chronic lithium administration. In some sense, this may be similar to other pharmacological effects on rodent behaviour that require much higher doses than those used in humans, such as imipramine in the Porsolt forced-swim test. However, at a mechanistic level, the implication must be that total inositol levels are too crude a measure to be of direct physiological relevance. Indeed, very large decreases in brain inositol can be achieved by osmotic manipulation without causing lithium-like behavioural effects [22] .
Smit1 knockout and Impa1 knockout seem different in the way that they choke off the brain's inositol supply and cause lithium-like effects. Homozygous Impa1 knockouts show pilocarpine-sensitivity and decreased immobility in the Porsolt forced-swim test, but without frontal cortex and hippocampus inositol level decrease [17] .
Antidepressant-like effects in the Porsolt forced-swim test have been reported in several mouse gene knockouts and thus there may be several genetic pathways to this phenotype, more or less specific [36] . Pilocarpine sensitivity does not have face validity as an animal model of lithium effects and may merely represent a 'bioassay' for inositol depletion [27, 37] . It may also not occur in humans [22, 38] , because of the high inositol concentration in human brain [39] . The Porsolt forced-swim test models antidepression action, although the unique and defining clinical effect of lithium is its antimanic action and long-term prophylactic action in bipolar disorder [40] . Thus the use of the Porsolt forced-swim test and the pilocarpine-sensitivity as animal behavioural models only supports, but does not prove, the inositol-depletion hypothesis. Since lithium seems to affect inositol levels both by inhibition of IMPase and by down-regulation of SMIT1, but it is unlikely that either of these effects are induced by lithium to the extent seen in a homozygous knockout mouse, it might be of interest to study double heterozygotes containing one allele knockout for both Smit1 and Impa1 to most closely mimic lithium effects on the inositol system.
Heterozygous Gsk3b-knockout mice
Knockout mutations in the gene encoding GSK3β caused a ∼40% decrease in GSK3β protein levels in the frontal cortex and in the hippocampus of Gsk3b −/+ knockout mice compared with Gsk3b +/+ littermates [23] . These data are consistent with findings of O'Brien et al. [28] . Surprisingly and unexpectedly, we could not confirm the finding of O'Brien et al. [28] and Beaulieu et al. [30] that Gsk3b −/+ knockout mice have lithium-like behaviour in the Porsolt forced-swim test and amphetamine-induced hyperactivity test [23] . In our laboratory, chronic lithium treatment leads to 80% decrease in immobility time in the Porsolt forced-swim test [23] similar to that reported by O'Brien et al. [28] . It is possible that a complex interaction between gene background differences and the Gsk3b knockout could explain the differences between our results and those of O'Brien et al. [28] . For example, the recent report that irradiation of the hippocampus prevents antidepressantinduced neurogenesis [41] was not replicated in different mice strains [42] . In this case, it would be difficult to consider the Gsk3b −/+ knockout as a robust model for further exploration of the mechanism of action of lithium on behaviour.
The inositol-depletion hypothesis of lithium action is based on lithium inhibition of IMPase and consequent depletion of intracellular inositol, the precursor for phosphatidylinositol cell signalling. This hypothesis is an alternative to the GSK3β inhibition hypothesis of lithium action [43] . In contrast with the above data with Gsk3b −/+ mice, we found that homozygous Smit1-knockout mice had a decrease of over 50% in brain inositol and marked lithium-like behaviour in the Porsolt forced-swim test and response to pilocarpine [23] . Moreover, homozygous Impa1-knockout mice were also found to have lithium-like sensitivity to pilocarpine and decreased immobility in the Porsolt forced-swim test, although an increase in general activity precluded a definitive interpretation of the results in the latter [17] . These results support inositol rather than GSK3β as the in vivo target for lithium action.
